GIUNCHI, VALENTINA
 Distribuzione geografica
Continente #
EU - Europa 362
NA - Nord America 135
AS - Asia 120
AF - Africa 19
OC - Oceania 12
SA - Sud America 4
Totale 652
Nazione #
IT - Italia 237
US - Stati Uniti d'America 125
SG - Singapore 59
CN - Cina 43
DE - Germania 18
SE - Svezia 15
CH - Svizzera 13
RU - Federazione Russa 13
FI - Finlandia 12
CI - Costa d'Avorio 11
NL - Olanda 10
AT - Austria 9
CA - Canada 9
BG - Bulgaria 8
IE - Irlanda 8
IN - India 8
AU - Australia 7
ID - Indonesia 7
NZ - Nuova Zelanda 5
BR - Brasile 4
TG - Togo 4
ES - Italia 3
PT - Portogallo 3
RS - Serbia 3
BE - Belgio 2
GB - Regno Unito 2
MA - Marocco 2
PL - Polonia 2
SI - Slovenia 2
FR - Francia 1
JO - Giordania 1
LK - Sri Lanka 1
LT - Lituania 1
MX - Messico 1
NG - Nigeria 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 652
Città #
Bologna 106
Singapore 45
Milan 24
Santa Clara 22
Boardman 12
Abidjan 11
Bern 11
Helsinki 10
Naples 9
Ashburn 8
Dublin 8
New York 8
Sofia 8
Vienna 8
Cesena 7
Jakarta 7
Embrun 6
Modena 6
Rome 6
Verona 6
Falkenstein 5
Florence 5
Turin 5
Amsterdam 4
Boydton 4
Lomé 4
Melbourne 4
Mercato Saraceno 4
Auckland 3
Barcelona 3
Bentivoglio 3
Dallas 3
Enschede 3
Jinan 3
Lisbon 3
Mülheim 3
Newcastle 3
Nijmegen 3
Novi Sad 3
Phoenix 3
Toronto 3
Brescia 2
Brussels 2
Chandler 2
Chengdu 2
Cinisello Balsamo 2
Dübendorf 2
Gislaved 2
Guangzhou 2
Hamilton 2
Lappeenranta 2
Ljubljana 2
Los Angeles 2
Maenza 2
Mönchengladbach 2
Prineville 2
Shanghai 2
Springfield 2
Stuttgart 2
Vaggeryd 2
Venice 2
Warsaw 2
Yubileyny 2
Amman 1
Arezzo 1
Beijing 1
Bellante 1
Berkeley Heights 1
Birmingham 1
Buffalo 1
Cesano Boscone 1
Changsha 1
Chongqing 1
Colombo 1
Council Bluffs 1
Dalmine 1
Foshan 1
Frankfurt am Main 1
Hangzhou 1
Johannesburg 1
Kharian 1
Kunming 1
Lagos 1
London 1
Mexico City 1
Moncalieri 1
Orlando 1
Padova 1
Paris 1
Parma 1
Pará de Minas 1
Pune 1
Reggio Emilia 1
Rio de Janeiro 1
San Cesario sul Panaro 1
Santa Bárbara d'Oeste 1
Seattle 1
Shenzhen 1
Suzhou 1
São Paulo 1
Totale 483
Nome #
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System 94
Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System 86
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System 79
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study 69
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 49
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies 49
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS 46
What Is the Safety Profile of Cannabis-Based Medications? Analysis of the Post-Marketing Signals from the FDA Adverse Event Reporting System 46
L’impatto ambientale dei farmaci sulle acque superficiali e la sua stima attraverso i dati di utilizzo 43
Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors 41
Post-marketing safety profile of cannabis products: Signals from the FDA adverse event reporting system 28
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System 22
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach 17
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health: Pharmaceutical Residues in the Environment: Threats to Ecosystems and Human Health 16
Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase 5
A pharmacological view on accounting for pharmacokinetic factors in the estimation of pharmaceutical emissions based on drug usage data 4
Environmental sustainability-an essential component of rational use of medicines 4
Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency 1
Totale 699
Categoria #
all - tutte 2.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.834


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023129 0 0 0 0 16 8 17 21 17 4 27 19
2023/2024196 10 11 25 34 21 23 1 18 6 14 21 12
2024/2025374 35 54 66 44 33 27 42 57 15 1 0 0
Totale 699